Alloy Ventures
182
18M
84
6.74
14
0.54
50
- Stages of investment
- Areas of investment
Summary
Alloy Ventures appeared to be the VC, which was created in 1996. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Palo Alto.
Besides them, we counted 4 critical employees of this fund in our database.
The typical startup value when the investment from Alloy Ventures is 50-100 millions dollars. The common things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 2 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 7-12 deals per year. The top activity for fund was in 2008. The top amount of exits for fund were in 2011. Opposing the other organizations, this Alloy Ventures works on 2 percentage points less the average amount of lead investments.
Among the most popular portfolio startups of the fund, we may highlight Pacific Biosciences, Cameron Health, SynergEyes. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most successful fund investment fields, there are Enterprise Software, Software. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Alloy Ventures, startups are often financed by Versant Ventures, Mohr Davidow Ventures, Sutter Hill Ventures. The meaningful sponsors for the fund in investment in the same round are Intel Capital, True Ventures, ARCH Venture Partners. In the next rounds fund is usually obtained by Sutter Hill Ventures, Intel Capital, True Ventures.
Investments analytics
Analytics
- Total investments
- 182
- Lead investments
- 14
- Exits
- 50
- Rounds per year
- 6.74
- Follow on index
- 0.54
- Investments by industry
- Software (55)
- Biotechnology (48)
- Health Care (36)
- Manufacturing (23)
- Mobile (21) Show 103 more
- Investments by region
-
- United States (176)
- Canada (2)
- Australia (1)
- Peak activity year
- 2008
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 41M
- Group Appearance index
- 0.95
- Avg. company exit year
- 10
- Avg. multiplicator
- 0.98
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Kalobios Pharmaceuticals, Inc. | 24 Jun 2004 | Biotechnology | Seed | 4M | United States, California, South San Francisco |
| Network Elements | 04 Jan 2001 | Early Stage Venture | 77M |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.